🎉 M&A multiples are live!
Check it out!

Guilin Sanjin Valuation Multiples

Discover revenue and EBITDA valuation multiples for Guilin Sanjin and similar public comparables like Pharming, Julphar, and Benevolent AI.

Guilin Sanjin Overview

About Guilin Sanjin

Guilin Sanjin Pharmaceutical Co Ltd is engaged in research and development of proprietary Chinese medicines and natural medicines.


Founded

2001

HQ

China
Employees

752

Website

sanjin.com.cn

Financials

LTM Revenue $317M

LTM EBITDA $73.2M

EV

$985M

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Guilin Sanjin Financials

Guilin Sanjin has a last 12-month revenue of $317M and a last 12-month EBITDA of $73.2M.

In the most recent fiscal year, Guilin Sanjin achieved revenue of $299M and an EBITDA of $89.5M.

Guilin Sanjin expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Guilin Sanjin valuation multiples based on analyst estimates

Guilin Sanjin P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue $299M $309M XXX XXX XXX
Gross Profit $178M $192M XXX XXX XXX
Gross Margin 60% 62% XXX XXX XXX
EBITDA $89.5M $71.0M XXX XXX XXX
EBITDA Margin 30% 23% XXX XXX XXX
Net Profit $47.4M $45.4M XXX XXX XXX
Net Margin 16% 15% XXX XXX XXX
Net Debt n/a n/a XXX XXX XXX

Financial data powered by Morningstar, Inc.

Guilin Sanjin Stock Performance

As of April 15, 2025, Guilin Sanjin's stock price is CNY 14 (or $2).

Guilin Sanjin has current market cap of CNY 8.0B (or $1.1B), and EV of CNY 7.1B (or $985M).

See Guilin Sanjin trading valuation data

Guilin Sanjin Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$985M $1.1B XXX XXX XXX XXX $0.11

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

Guilin Sanjin Valuation Multiples

As of April 15, 2025, Guilin Sanjin has market cap of $1.1B and EV of $985M.

Guilin Sanjin's trades at 3.1x LTM EV/Revenue multiple, and 13.5x LTM EBITDA.

Analysts estimate Guilin Sanjin's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for Guilin Sanjin and 10K+ public comps

Guilin Sanjin Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $985M XXX XXX XXX
EV/Revenue 3.2x XXX XXX XXX
EV/EBITDA 13.9x XXX XXX XXX
P/E 17.9x XXX XXX XXX
P/E/Growth 1.4x XXX XXX XXX
EV/FCF n/a XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Guilin Sanjin Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

Guilin Sanjin Valuation Multiples

Guilin Sanjin's NTM/LTM revenue growth is 9%

Guilin Sanjin's revenue per employee for the last fiscal year averaged $0.4M, while opex per employee averaged $0.2M for the same period.

Over next 12 months, Guilin Sanjin's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate Guilin Sanjin's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for Guilin Sanjin and other 10K+ public comps

Guilin Sanjin Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth 3% XXX XXX XXX XXX
EBITDA Margin 23% XXX XXX XXX XXX
EBITDA Growth -21% XXX XXX XXX XXX
Rule of 40 (SaaS-only) 32% XXX XXX XXX XXX
Revenue per Employee $0.4M XXX XXX XXX XXX
Opex per Employee $0.2M XXX XXX XXX XXX
S&M Expenses to Revenue 27% XXX XXX XXX XXX
G&A Expenses to Revenue 5% XXX XXX XXX XXX
R&D Expenses to Revenue 7% XXX XXX XXX XXX
Opex to Revenue 49% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Guilin Sanjin Public Comps

See public comps and valuation multiples for Drug Development & Therapeutics comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Julphar XXX XXX XXX XXX XXX XXX
Benevolent AI XXX XXX XXX XXX XXX XXX
Galapagos XXX XXX XXX XXX XXX XXX
Pharming XXX XXX XXX XXX XXX XXX
Vivoryon Therapeutics XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Guilin Sanjin M&A and Investment Activity

Guilin Sanjin acquired  XXX companies to date.

Last acquisition by Guilin Sanjin was  XXXXXXXX, XXXXX XXXXX XXXXXX . Guilin Sanjin acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Guilin Sanjin

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About Guilin Sanjin

When was Guilin Sanjin founded? Guilin Sanjin was founded in 2001.
Where is Guilin Sanjin headquartered? Guilin Sanjin is headquartered in China.
How many employees does Guilin Sanjin have? As of today, Guilin Sanjin has 752 employees.
Is Guilin Sanjin publicy listed? Yes, Guilin Sanjin is a public company listed on SHE.
What is the stock symbol of Guilin Sanjin? Guilin Sanjin trades under 002275 ticker.
When did Guilin Sanjin go public? Guilin Sanjin went public in 2009.
Who are competitors of Guilin Sanjin? Similar companies to Guilin Sanjin include e.g. Julphar, Benevolent AI, Galapagos, Pharming.
What is the current market cap of Guilin Sanjin? Guilin Sanjin's current market cap is $1.1B
What is the current revenue of Guilin Sanjin? Guilin Sanjin's last 12-month revenue is $317M.
What is the current EBITDA of Guilin Sanjin? Guilin Sanjin's last 12-month EBITDA is $73.2M.
What is the current EV/Revenue multiple of Guilin Sanjin? Current revenue multiple of Guilin Sanjin is 3.1x.
What is the current EV/EBITDA multiple of Guilin Sanjin? Current EBITDA multiple of Guilin Sanjin is 13.5x.
What is the current revenue growth of Guilin Sanjin? Guilin Sanjin revenue growth between 2023 and 2024 was 3%.
Is Guilin Sanjin profitable? Yes, Guilin Sanjin is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.